All Stories

  1. Characterization of a novel Mycoplasma cynos real-time PCR assay

    Article • Journal of Veterinary Diagnostic Investigation, November 2019, SAGE Publications

    Laura Goodman

  2. Inhibition monitoring in veterinary molecular testing

    Article • Journal of Veterinary Diagnostic Investigation, November 2019, SAGE Publications

    Laura Goodman

  3. Impact of confinement housing on study end-points in the calf model of cryptosporidiosis

    Article • PLoS Neglected Tropical Diseases, April 2018, PLOS

    Laura Goodman

  4. Lactococcus petauri sp. nov., isolated from an abscess of a sugar glider

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, November 2017, Society for General Microbiology

    Laura Goodman, Martin Wiedmann Wiedmann

  5. Detection of Salmonella spp. in veterinary samples by combining selective enrichment and real-time PCR

    Article • Journal of Veterinary Diagnostic Investigation, September 2017, SAGE Publications

    Laura Goodman

  6. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

    Article • Nature, May 2017, Nature

    Laura Goodman

  7. A Point Mutation in a Herpesvirus Co-Determines Neuropathogenicity and Viral Shedding

    Article • Viruses, January 2017, MDPI AG

    Laura Goodman

  8. Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age

    Article • PLoS ONE, January 2017, PLOS

    Laura Goodman

  9. High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

    Article • Journal of Visualized Experiments, November 2016, MyJove Corporation

    Laura Goodman

  10. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine

    Article • Vaccine, October 2015, Elsevier

    Laura Goodman

  11. Maternal T-lymphocytes in equine colostrum express a primarily inflammatory phenotype

    Article • Veterinary Immunology and Immunopathology, October 2014, Elsevier

    Laura Goodman

  12. Antibodies to OspC, OspF and C6 antigens as indicators for infection withBorrelia burgdorferiin horses

    Article • Equine Veterinary Journal, February 2013, Wiley

    Laura Goodman

  13. Evolutionary Reconstructions of the Transferrin Receptor of Caniforms Supports Canine Parvovirus Being a Re-emerged and Not a Novel Pathogen in Dogs

    Article • PLoS Pathogens, May 2012, PLOS

    Laura Goodman

  14. Immunological Correlates of Vaccination and Infection for Equine Herpesvirus 1

    Article • Clinical and Vaccine Immunology, December 2011, ASM Journals

    Laura Goodman

  15. Binding Site on the Transferrin Receptor for the Parvovirus Capsid and Effects of Altered Affinity on Cell Uptake and Infection

    Article • Journal of Virology, March 2010, ASM Journals

    Laura Goodman

  16. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984–2007)

    Article • Veterinary Microbiology, November 2009, Elsevier

    Laura Goodman

  17. Detection of Equine Herpesvirus‐1 in Nasal Swabs of Horses by Quantitative Real‐Time PCR

    Article • Journal of Veterinary Internal Medicine, August 2008, Wiley

    Laura Goodman

  18. A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity

    Article • PLoS Pathogens, November 2007, PLOS

    Professor Arianna Loregian, Laura Goodman

  19. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)

    Article • Virus Research, April 2007, Elsevier

    Laura Goodman

  20. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)

    Article • Vaccine, April 2006, Elsevier

    Laura Goodman

  21. Equine herpesvirus type 1 modified live virus vaccines:quo vaditis?

    Article • Expert Review of Vaccines, February 2006, Taylor & Francis

    Laura Goodman

  22. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS

    Article • Drug Metabolism and Disposition, January 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Laura Goodman

  23. Human Hepatic CYP2E1 Expression during Development

    Article • Journal of Pharmacology and Experimental Therapeutics, September 2003, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Ronald N. Hines, Laura Goodman